EDTUTC-4 New YorkLog in Sign up

ERNA
Ernexa Therapeutics Inc. Common Stock
stockNASDAQ

At CloseOct 6, 2026 3:59:50 PM EDT

2.23USD0.000%(-0.00)82,901

1.9200Bid3.2400Ask1.3200Spread

Pre-marketOct 7, 2026 8:42:30 AM EDT

2.2076USD-1.226%(-0.0274)

After-hoursOct 7, 2026 4:59:30 PM EDT

3.26USD+45.861%(+1.02)

ERNA News

Day breaks

08:55 AM EDTErnexa Therapeutics’ ERNA-101 Selected for Flash Talk Presentation at Nature Conferences’ Next-Generation Cancer Therapeutics Meeting Co-Hosted by MD Anderson Cancer Center ·

GlobeNewswire Inc.

09:20 AM EDTErnexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic ·

GlobeNewswire Inc.

09:12 AM EDTErnexa Reports Positive ERNA-101 Safety Data Ahead Of Q4 IND ·

RTTNews

08:32 AM EDTErnexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND ·

GlobeNewswire Inc.

09:15 AM EDTErnexa Therapeutics Selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa, Highlighting ERNA-101 and Focused Oncology Strategy ·

GlobeNewswire Inc.

08:42 AM EDTErnexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors ·

GlobeNewswire Inc.

08:42 AM EDTErnexa Therapeutics Reports Positive Disease Modifying ERNA-201 Preclinical Data, Reinforcing iMSC Platform as Company Accelerates Oncology Strategy and ERNA-101 Toward First-in-Human Dosing ·

GlobeNewswire Inc.